GPACTS Global Pharma AI Summit Hyderabad 2026: AI, Compliance and Smart Manufacturing

Hyderabad is set to become the center of India’s pharmaceutical technology landscape as the Global Pharma AI, Compliance & Technology Summit (GPACTS) prepares to host its largest edition yet. The flagship event is expected to bring together 350 to 400 senior executives, technology leaders, compliance experts, and manufacturing professionals from across the pharmaceutical industry to explore how artificial intelligence is transforming regulated drug manufacturing and digital healthcare operations.

The summit reflects the growing importance of AI, automation, cybersecurity, and compliance in pharmaceutical production. As pharmaceutical companies accelerate investments in digital technologies, they must also ensure that every innovation meets strict regulatory standards related to quality, validation, data integrity, and patient safety. GPACTS aims to create a platform where these critical business and regulatory discussions happen together.

Unlike traditional technology conferences, the Hyderabad summit is specifically designed for regulated pharmaceutical manufacturing environments. The agenda focuses on practical implementation rather than high-level technology discussions, helping organizations understand how AI and digital systems can be deployed while remaining compliant with industry regulations and quality standards.

One of the major themes of the summit is AI governance in pharmaceutical manufacturing. Industry experts will discuss how artificial intelligence can be safely integrated into validated production environments without compromising compliance requirements. Sessions will also explore digital batch manufacturing, manufacturing execution systems (MES), laboratory information management systems, connected quality platforms, digital twins, and intelligent production monitoring.

As pharmaceutical companies continue modernizing factories and laboratories, connected manufacturing systems are becoming essential for improving productivity and operational visibility. AI-powered analytics, automation platforms, and real-time quality monitoring are helping manufacturers reduce errors, improve traceability, and accelerate production while maintaining regulatory compliance.

Cybersecurity will also be a major focus of the event. As manufacturing equipment, laboratory systems, and enterprise software become increasingly connected, protecting sensitive production data and preventing cyber threats has become a top priority for pharmaceutical organizations. Experts will discuss strategies for securing digital infrastructure, safeguarding validated systems, and maintaining data integrity across manufacturing operations.

The Hyderabad edition is supported by leading technology companies working closely with the life sciences industry. These organizations contribute expertise in automation, connected operations, laboratory technologies, manufacturing intelligence, and enterprise quality management systems, highlighting the growing collaboration between pharmaceutical manufacturers and technology providers.

The summit will feature several prominent speakers from pharmaceutical, healthcare, regulatory, and technology sectors. These leaders will share real-world experiences in implementing AI, digital transformation strategies, quality IT systems, manufacturing automation, and enterprise technology across some of India’s leading pharmaceutical companies.

Previous GPACTS events held in Mumbai and Ahmedabad demonstrated strong demand for implementation-focused discussions. More than 80 percent of attendees at earlier editions represented pharmaceutical organizations, while a significant share consisted of C-suite executives and senior decision-makers. This growing participation indicates that AI and digital compliance have become strategic priorities for pharmaceutical leadership rather than just IT departments.

One of the standout features from previous editions was a live ransomware simulation built around a pharmaceutical manufacturing scenario. The exercise demonstrated how cybersecurity incidents can affect production, compliance, and business continuity simultaneously. Similar practitioner-led sessions are expected in Hyderabad, offering participants hands-on insights into managing operational risks in regulated environments.

The summit’s implementation-first approach recognizes that digital transformation in pharmaceuticals is more complex than adopting new software. Every AI model, automation platform, laboratory system, or manufacturing application must satisfy established validation procedures, maintain secure audit trails, and comply with global regulatory expectations. This balance between innovation and compliance has become one of the industry’s biggest challenges.

Artificial intelligence is increasingly being used across pharmaceutical operations, including predictive maintenance, production optimization, quality inspection, document automation, clinical data analysis, supply chain forecasting, and laboratory workflows. However, organizations must also address governance frameworks, explainability, validation, and cybersecurity before deploying AI at scale in regulated manufacturing facilities.

Hyderabad’s position as one of India’s leading pharmaceutical and life sciences hubs makes it a natural destination for the summit. The city is home to major pharmaceutical manufacturers, biotechnology companies, research organizations, and technology providers driving innovation across healthcare and drug production.

The event is expected to encourage collaboration between manufacturing teams, IT leaders, compliance officers, cybersecurity specialists, digital transformation professionals, and regulatory experts. By bringing these groups together, GPACTS aims to help organizations move from digital transformation planning to responsible and compliant implementation.

As the pharmaceutical industry enters a new era of AI-driven manufacturing, events like the Global Pharma AI, Compliance & Technology Summit are becoming increasingly important for sharing practical knowledge, addressing regulatory challenges, and exploring technologies that improve operational efficiency without compromising quality or compliance.

With its largest gathering to date, the Hyderabad summit is expected to play a significant role in shaping discussions around AI-powered pharmaceutical manufacturing, digital compliance, cybersecurity, and smart factory transformation across India’s life sciences sector.